(Q44473775)

3 December 2017

Central muscarinic acetylcholine receptor availability in patients treated with clozapine (English)

1 reference

3 December 2017

6

Daniel R Weinberger

1 reference

3 December 2017

Thomas J Raedler

1

1 reference

3 December 2017

Michael B Knable

2

1 reference

3 December 2017

Douglas W Jones

3

1 reference

3 December 2017

Richard A Urbina

4

1 reference

3 December 2017

Michael F Egan

5

1 reference

3 December 2017

language of work or name

English

0 references

publication date

11 June 2003

1 reference

3 December 2017

Neuropsychopharmacology

1 reference

3 December 2017

28

1 reference

3 December 2017

8

1 reference

3 December 2017

1531-1537

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300210

3 December 2017

0 references

cites work

Radioreceptor binding profile of the atypical antipsychotic olanzapine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300210

The binding of [3H]AF-DX 384 is reduced in the caudate-putamen of subjects with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300210

Decreased muscarinic receptor binding in subjects with schizophrenia: a study of the human hippocampal formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300210

Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300210

Positron emission tomography (PET) studies of dopaminergic/cholinergic interactions in the baboon brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300210

Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300210

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300210

Contrasts between patients with affective disorders and patients with schizophrenia on a neuropsychological test battery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300210

Eye-Tracking Patterns in Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300210

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300210

High 5-HT2 receptor occupancy in clozapine treated patients demonstrated by PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300210

Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300210

Individual variation in D2 dopamine receptor occupancy in clozapine-treated patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300210

In vivo determination of muscarinic acetylcholine receptor availability in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300210

A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300210

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300210

Differential cholinergic regulation in Alzheimer's patients compared to controls following chronic blockade with scopolamine: a SPECT study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300210

Muscarinic cholinergic hyperactivity in schizophrenia. Relationship to positive and negative symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300210

5-HT2A receptor blockade in patients with schizophrenia treated with risperidone or clozapine. A SPET study using the novel 5-HT2A ligand 123I-5-I-R-91150.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300210

The distribution of cerebral muscarinic acetylcholine receptors in vivo in patients with dementia. A controlled study with 123IQNB and single photon emission computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300210

Muscarinic m4 receptor activation by some atypical antipsychotic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300210

Clozapine is a potent and selective muscarinic M4 receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300210

External imaging of cerebral muscarinic acetylcholine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300210

7 January 2021

Sleep EEG studies in untreated, long-term schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300210

7 January 2021

Clozapine interaction with the M2 and M4 subtypes of muscarinic receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300210

7 January 2021

D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300210

7 January 2021

Mixed agonist-antagonist properties of clozapine at different human cloned muscarinic receptor subtypes expressed in Chinese hamster ovary cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300210

7 January 2021

In vivo olanzapine occupancy of muscarinic acetylcholine receptors in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300210

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300210

1 reference

3 December 2017

1 reference